Preferred Label : Ezetimibe;
MeSH definition : An azetidine derivative and ANTICHOLESTEREMIC AGENT that inhibits intestinal STEROL
absorption. It is used to reduce total CHOLESTEROL; LDL CHOLESTEROL, and APOLIPOPROTEINS
B in the treatment of HYPERLIPIDEMIAS.;
MeSH synonym : (1-(4-fluorophenyl)-(3R)-(3-(4-fluorophenyl)-(3S)-hydroxypropyl)-(4S)-(4-hydroxyphenyl)-2-azetidinone); Ezetimib;
MeSH hyponym : ezetrol; zetia; SCH 58235; 58235, SCH; SCH-58235; SCH58235;
MeSH Related Number : 163222-33-1;
Wikipedia link : https://en.wikipedia.org/wiki/Zetia;
Is substance : O;
UNII : EOR26LQQ24;
Origin ID : D000069438;
UMLS CUI : C1142985;
ATC code(s)
Allowable qualifiers
Pharmacological action(s)
Record concept(s)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
An azetidine derivative and ANTICHOLESTEREMIC AGENT that inhibits intestinal STEROL
absorption. It is used to reduce total CHOLESTEROL; LDL CHOLESTEROL, and APOLIPOPROTEINS
B in the treatment of HYPERLIPIDEMIAS.
https://ansm.sante.fr/actualites/decision-dautorisation-dimportation-parallele-accordee-le-21-03-2024-suvreza-20-mg-10-mg-comprime-pellicule
2024
false
false
false
France
French
drug information
legislation, pharmacy
drug combinations
Ezetimibe
Rosuvastatin Calcium
rosuvastatin and ezetimibe
spain
---
https://www.has-sante.fr/jcms/p_3509116/fr/junaliza-atorvastatine/ezetimibe-hypolipidemiants-en-association
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
administration, oral
Ezetimibe
Atorvastatin
atorvastatin calcium
atorvastatin and ezetimibe
hypercholesterolemia
non-familial primary hypercholesterolemia
Familial hypercholesterolemia - heterozygous (disorder)
Mixed Hyperlipidemia
adult
evaluation of the transparency committee
drug combinations
hypolipidemic agents
---
Ezetrol (ezetimibe) and the Risks of Drug-Induced Liver Injury and Severe Cutaneous
Adverse Reactions
https://recalls-rappels.canada.ca/fr/avis-rappel/ezetrol-ezetimibe-et-risques-lesions-hepatiques-origine-medicamenteuse-et-reactions
2024
false
false
false
Canada
French
English
pharmacovigilance note
Ezetimibe
Chemical and Drug Induced Liver Injury
Drug-Induced Liver Disease
drug hypersensitivity syndrome
stevens-johnson syndrome
epidermal necrolysis, toxic
Drug-Induced stevens johnson syndrome
canada
administration, oral
ezetimibe
anticholesteremic agents
---
https://ansm.sante.fr/actualites/decision-dautorisation-dimportation-parallele-accordee-le-27-03-2023-liptruzet-10-mg-20-mg-comprime-pellicule
2023
false
false
false
France
French
legislation
drug information
france
administration, oral
drug combinations
atorvastatin calcium
Ezetimibe
atorvastatin and ezetimibe
---
https://www.has-sante.fr/jcms/p_3455991/fr/junaliza-atorvastatine-/-ezetimibe-hypolipidemiants-en-association
2023
false
false
false
France
administration, oral
treatment outcome
insurance, health, reimbursement
hypercholesterolemia
adult
Primary hypercholesterolemia (disorder)
atorvastatin and ezetimibe
evaluation of the transparency committee
hypolipidemic agents
drug combinations
Atorvastatin
Ezetimibe
---
https://www.has-sante.fr/jcms/p_3471816/fr/suvreza-rosuvastatine-calcique/ezetimibe-hypercholesterolemie
2023
false
false
false
France
insurance, health, reimbursement
treatment outcome
drug combinations
Ezetimibe
Rosuvastatin Calcium
anticholesteremic agents
hydroxymethylglutaryl-coa reductase inhibitors
administration, oral
rosuvastatin and ezetimibe
adult
hypercholesterolemia
Primary hypercholesterolemia (disorder)
Familial hypercholesterolemia - heterozygous (disorder)
evaluation of the transparency committee
---
https://www.has-sante.fr/jcms/p_3217176/fr/reselip
2020
false
false
false
France
insurance, health, reimbursement
treatment outcome
drug combinations
Atorvastatin
Ezetimibe
hydroxymethylglutaryl-coa reductase inhibitors
atorvastatin and ezetimibe
hypercholesterolemia
Familial hypercholesterolemia - heterozygous (disorder)
Familial hypercholesterolemia - homozygous (disorder)
Primary hypercholesterolemia (disorder)
adult
mixed dyslipidemia
dyslipidemias
administration, oral
evaluation of the transparency committee
---
https://www.ema.europa.eu/en/medicines/human/EPAR/nustendi
2020
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug combinations
drug approval
europe
8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid
8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid
Ezetimibe
Ezetimibe
anticholesteremic agents
anticholesteremic agents
ATP citrate (pro-S)-Lyase
hypercholesterolemia
Primary hypercholesterolaemia
dyslipidemias
mixed dyslipidemia
adult
aged
administration, oral
bempedoic acid and ezetimibe
NPC1-Like Intracellular Cholesterol Transporter 1
product surveillance, postmarketing
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
dicarboxylic acids
fatty acids
dicarboxylic acids
fatty acids
---
https://pharmacomedicale.org/medicaments/par-specialites/item/inhibiteurs-de-l-absorption-intestinale-des-sterols
2019
false
false
false
France
anticholesteremic agents
Ezetimibe
drug combinations
hypercholesterolemia
cardiovascular diseases
drug information
---
https://www.has-sante.fr/jcms/p_3122523/fr/ezetrol
2019
false
false
false
France
ezetimibe
insurance, health, reimbursement
sitosterolemia
coronary disease
cardiovascular diseases
hypercholesterolemia
hyperlipoproteinemia type ii
administration, oral
treatment outcome
anticholesteremic agents
evaluation of the transparency committee
Ezetimibe
intestinal diseases
lipid metabolism, inborn errors
phytosterols
phytosterols
---
https://www.has-sante.fr/jcms/p_3107047/fr/suvreza
2019
false
false
false
France
rosuvastatin and ezetimibe
drug combinations
adult
Rosuvastatin Calcium
Ezetimibe
treatment outcome
administration, oral
hydroxymethylglutaryl-coa reductase inhibitors
anticholesteremic agents
hypercholesterolemia
Familial hypercholesterolemia - homozygous (disorder)
Primary hypercholesterolemia (disorder)
evaluation of the transparency committee
---
https://www.has-sante.fr/portail/jcms/c_2972299/fr/twicor
2019
false
false
false
France
French
drug combinations
rosuvastatin
Ezetimibe
treatment outcome
insurance, health, reimbursement
administration, oral
hydroxymethylglutaryl-coa reductase inhibitors
anticholesteremic agents
hypercholesterolemia
evaluation of the transparency committee
Rosuvastatin Calcium
---
https://www.has-sante.fr/portail/jcms/c_2863024/fr/liporosa
2018
false
false
false
false
France
French
evaluation of the transparency committee
administration, oral
drug combinations
treatment outcome
insurance, health, reimbursement
rosuvastatin
rosuvastatin
Hydroxymethylglutaryl-CoA reductase inhibitors
Hydroxymethylglutaryl-CoA reductase inhibitors
rosuvastatin and ezetimibe
Ezetimibe
Ezetimibe
anticholesteremic agents
anticholesteremic agents
hypercholesterolemia
Primary hypercholesterolemia (disorder)
Rosuvastatin Calcium
Rosuvastatin Calcium
hydroxymethylglutaryl-coa reductase inhibitors
hydroxymethylglutaryl-coa reductase inhibitors
---
https://www.cochrane.org/fr/CD012502/lezetimibe-pour-la-prevention-des-maladies-cardiaques-et-des-deces
2018
false
false
false
France
United Kingdom
heart diseases
anticholesteremic agents
treatment outcome
Evidence-Based medicine
review of literature
french abstract
heart diseases
Ezetimibe
---
https://www.has-sante.fr/portail/jcms/c_2798549/fr/ezetimibe-accord
2017
false
false
false
France
French
evaluation of the transparency committee
Ezetimibe
---
http://www.has-sante.fr/portail/jcms/c_2756458/fr/ezetrol
2017
false
false
false
France
French
evaluation of the transparency committee
Ezetimibe
coronary disease
---
https://minerva-ebp.be/FR/Article/2041
2016
false
false
false
false
Belgium
French
Dutch
critical appraisal or critical reading
drug therapy, combination
Ezetimibe
simvastatin
Ezetimibe, Simvastatin Drug Combination
treatment outcome
acute coronary syndrome
anticholesteremic agents
hydroxymethylglutaryl-coa reductase inhibitors
cardiovascular diseases
cardiovascular diseases
cardiovascular diseases
simvastatin
simvastatin and ezetimibe
ezetimibe
---
http://www.has-sante.fr/portail/jcms/c_2629878/fr/ezetrol
2016
true
France
French
hypercholesterolemia
sitosterolemia
Ezetimibe
drug therapy, combination
hydroxymethylglutaryl-coa reductase inhibitors
administration, oral
insurance, health, reimbursement
ezetimibe
treatment outcome
anticholesteremic agents
evaluation of the transparency committee
intestinal diseases
lipid metabolism, inborn errors
phytosterols
---
http://www.has-sante.fr/portail/jcms/c_2025250/fr/ezetrol
2015
true
France
French
hypercholesterolemia
sitosterolemia
Ezetimibe
administration, oral
insurance, health, reimbursement
ezetimibe
treatment outcome
anticholesteremic agents
evaluation of the transparency committee
intestinal diseases
lipid metabolism, inborn errors
phytosterols
---
http://circulaire.legifrance.gouv.fr/index.php?action=afficherCirculaire&hit=1&r=39060
http://circulaire.legifrance.gouv.fr/pdf/2014/12/cir_39060.pdf
2015
false
false
false
France
French
legislation, pharmacy
insurance, health, reimbursement
rosuvastatin
hydroxymethylglutaryl-coa reductase inhibitors
ezetimibe
legislation
anticholesteremic agents
forms
simvastatin and ezetimibe
Ezetimibe, Simvastatin Drug Combination
Ezetimibe
Rosuvastatin Calcium
---
http://www.has-sante.fr/portail/jcms/c_2024177/fr/liptruzet
http://www.has-sante.fr/portail/jcms/c_2024177/fr/liptruzet-ezetimibe/atorvastatine-association-fixe-d-hypocholesterolemiants
2015
false
false
false
France
French
evaluation of the transparency committee
liptruzet
drug combinations
treatment outcome
insurance, health, reimbursement
hydroxymethylglutaryl-coa reductase inhibitors
hydroxymethylglutaryl-coa reductase inhibitors
adult
hypercholesterolemia
anticholesteremic agents
anticholesteremic agents
administration, oral
atorvastatin and ezetimibe
Familial hypercholesterolemia - homozygous (disorder)
guidelines for drug use
Atorvastatin
Atorvastatin
Ezetimibe
Ezetimibe
mixed dyslipidemia
---
http://www.has-sante.fr/portail/jcms/c_2580468/fr/ezetrol
http://www.has-sante.fr/portail/jcms/c_813333/ezetrol
2015
false
France
French
hypercholesterolemia
sitosterolemia
Familial hypercholesterolemia - homozygous (disorder)
Homozygous sitosterolemia (disorder)
Primary hypercholesterolemia (disorder)
Ezetimibe
administration, oral
insurance, health, reimbursement
ezetimibe
treatment outcome
anticholesteremic agents
evaluation of the transparency committee
intestinal diseases
lipid metabolism, inborn errors
phytosterols
---
http://www.has-sante.fr/portail/jcms/c_849310/ezetrol-ezetimibe-hypocholesterolemiant
http://www.has-sante.fr/portail/jcms/c_813481/ezetrol-ct-6429
http://www.has-sante.fr/portail/jcms/c_849307/synthese-d-avis-ezetrol-ct-6429
2009
false
France
French
Primary hypercholesterolemia (disorder)
Ezetimibe
Ezetimibe
anticholesteremic agents
administration, oral
ezetimibe
insurance, health, reimbursement
treatment outcome
anticholesteremic agents
drug therapy, combination
hydroxymethylglutaryl-coa reductase inhibitors
evaluation of the transparency committee
guidelines for drug use
---
https://www.jle.com/fr/revues/medecine/med/e-docs/00/04/14/88/resume.md?type=text.html
2006
false
France
French
Ezetimibe
anticholesteremic agents
rhabdomyolysis
cholesterol
drug evaluation
journal article
---
http://www.has-sante.fr/portail/display.jsp?id=c_498794
2006
false
France
French
Primary hypercholesterolemia (disorder)
Ezetimibe, Simvastatin Drug Combination
Ezetimibe
mixed dyslipidemia
hypercholesterolemia
anticholesteremic agents
hydroxymethylglutaryl-coa reductase inhibitors
muscles
rhabdomyolysis
anticholesteremic agents
drug therapy, combination
simvastatin and ezetimibe
ezetimibe
guidelines for drug use
algorithms
---
https://www.amub-ulb.be/system/files/rmb/old/192
2005
false
Belgium
French
Ezetimibe
hypolipidemic agents
fatty acids, Omega-3
piperidines
niacin
anticholesteremic agents
pyrazoles
docosahexaenoic acids
eicosapentaenoic acid
Omacor
drug combinations
journal article
Rimonabant
---
https://www.amub-ulb.be/system/files/rmb/old/136
2004
false
Belgium
French
Ezetimibe
Ezetimibe
anticholesteremic agents
anticholesteremic agents
journal article
---
https://rmlg.uliege.be/article/1047
2004
false
Belgium
French
Primary hypercholesterolemia (disorder)
Ezetimibe
Ezetimibe
drug therapy, combination
anticholesteremic agents
anticholesteremic agents
hypercholesterolemia
cardiovascular diseases
hydroxymethylglutaryl-coa reductase inhibitors
ezetimibe
drug information
journal article
---
https://www.cadth.ca/sites/default/files/pdf/108_No27_ezetimibe_edrug_f.pdf
2002
false
Canada
French
Ezetimibe
anticholesteremic agents
hypercholesterolemia
clinical trials as topic
ezetimibe
drug evaluation
---